FOX59 News

Circular Genomics Announces Closure of $15 Million Series A Financing to Advance First-in-Class Circular RNA Platform for Early Detection of Alzheimer's Disease

Financing accelerates clinical validation and commercial readiness, as circular RNAs emerge as a new category of brain-derived blood biomarkers with best-in-class performance SAN DIEGO, Dec. 1, 2025 ...
U.S. News & World Report

10x Genomics Inc - Ordinary Shares - Class A

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, ...
FOX59 News

Circular Genomics to Unveil New Data Highlighting Circular RNAs as a Transformative New Class of Blood-Based Biomarkers for Alzheimer's Disease at CTAD 2025

New clinical data highlights circular RNAs (circRNAs) as a novel, non-invasive blood biomarker platform for the early detection of Alzheimer's Disease (AD). The research demonstrates that circRNAs ...
Yahoo Finance

Manhattan Genomics Unveils World-Class Scientific Team to Pioneer New Era of Genomic Medicine and Eradicate Inherited Disease

Company taps John R. Quain, Norbert Gleicher, MD, Carol Hanna, Ph.D, Jon Hennebold, Ph.D, and Stephen Turner, Ph.D to its world-class team to advance responsible genomic medicine. NEW YORK, October 30 ...
The Michigan Daily

Students produce videos to learn about genomics

Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Since the beginning of the semester, students in Biology 144 have been creating documentary ...
News Medical

Deep Genomics receives $13 million investment to create new class of genetic drugs

Deep Genomics, the AI driven genetic medicine company, received a USD $13 million equity investment led by Khosla Ventures, one of the top venture capital firms. They are accompanied by early stage ...